This episode of Industry Focus is brought to you by Sinios Health,

and you fully integrated bio-pharmaceutical solutions organization,

that's the result of a merger between INC research and inventive health.

CINios Health is focused on a simple end goal,

shortening the distance from lab to life.

To learn more, visit Cineos Health.

com slash podcast.

Welcome to Industry Focus, the show that dives into a different sector of the stock market every day.

Today is Wednesday, December the 19th, and we're talking health care.

I'm your host Shannon Jones and I am joined if he is Skype by a special guest, Motley

Full Explorer, Lead Advisor Simon Ericsson,son Simon how are you?

I'm doing great Shannon. This is always a pleasure chatting with you so thanks for having me.

Anytime and I'm super excited about you joining for this show for our listeners that aren't aware, Simon

literally scours the globe for the next big thing in his service, Motley Full

Explorer. And so no better a person to have on the show to talk about what I think is been a question I know we've gotten to industry focus

Something that's been on the minds of a lot of biotech investors, but it's one of the hottest areas of investment right now and that is the Chinese

biotech market.

So Simon, I'm excited to dig into this today with you, but let's kind of set the stage because if you're like

me I kind of look at the Chinese market in some ways like the emerging biotech

market in the US in the early 90s.

It was rife with problems, really wasn't efficient,

and you can see how far we've come since then.

...